Catalysts for OrphAI Therapeutics Inc
6 tracked
Apr 1, 2026
device pma
Biotronik, Inc. — ORSIRO Sirolimus Eluting Coronary Stent System; Synsiro Pro Sirolimus Eluting Coronary Stent System (PMA supplement)
OrphAI Therapeutics Inc
→
Feb 22, 2026
device pma
Biotronik, Inc. — Orsiro Mission Sirolimus Eluting Coronary Stent System; Synsiro Pro Sirolimus Eluting Coronary Stent System (PMA supplement)
OrphAI Therapeutics Inc
→
Feb 20, 2026
device pma
Biotronik, Inc. — Orsiro Mission Sirolimus Eluting Coronary Stent System, Synsiro Pro Sirolimus Eluting Coronary Stent System (PMA supplement)
OrphAI Therapeutics Inc
→
Oct 10, 2025
device pma
Biotronik, Inc. — Orsiro Mission Sirolimus Eluting Coronary Stent System (PMA supplement)
OrphAI Therapeutics Inc
→
Aug 19, 2025
device pma
Biotronik, Inc. — Orsiro Mission Sirolimus Eluting Coronary Stent System; Synsiro Pro Sirolimus Eluting Coronary Stent System (PMA supplement)
OrphAI Therapeutics Inc
→
Jul 10, 2025
device pma
Biotronik, Inc. — Orsiro Mission Sirolimus Eluting Coronary Stent System (PMA supplement)
OrphAI Therapeutics Inc
→